Topics
Cardiovascular diseases
Are high coronary risk patients missing out on lipid-lowering drugs in Australia?
Middle-aged patients with multiple risk factors appear to be well managed, but other age groups may be missing out
Leon A Simons MD, FRACP · Eric Chung BE(Comp), MBA
The promise of high-sensitivity troponin testing
Judging when troponin testing is best done, in general practice and beyond
Derek P B Chew MB BS, MPH, FRACP · Louise Cullen MB BS, FACEM
A systematic approach to chronic heart failure care: a consensus statement
Recommendations to reduce emergency presentations, hospitalisations and premature death from CHF
Karen Page RN, DN, BEd · Thomas H Marwick MB BS, PhD, MPH · Rebecca Lee BPharm, MPH · Robert Grenfell MB BS, MPH, FAFPHM · Walter P Abhayaratna FRACP, FACC, DrPH · Anu Aggarwal MB BS, FRACP, PhD · Tom G Briffa PhD · Jan Cameron PhD, MHSc(HealthProm · Patricia M Davidson RN, PhD · Andrea Driscoll PhD · Jacquie Garton-Smith MB BS, FRACGP · Debra J Gascard BN, MNP, NP · Annabel Hickey MMSc(ClinEpi), BApp(OT) · Dariusz Korczyk FRACP, FCSANZ · Julie-Anne Mitchell MPH, BA, RN · Rhonda Sanders RN, MNSt · Deborah Spicer MNg(NP), GradDip(CVNursing), BN · Simon Stewart PhD · Vicki Wade DipAppSci, BHS, MN
Should general practitioners order troponin tests?
GPs should use troponin tests cautiously, aware of sensitivity and predictive value
George A Marshall MB ChB, FRCPA · Nilika G Wijeratne MB BS, FRCPA, FAACB · Devika Thomas MB BS, MSurg, FRCPA,
Impact of high-sensitivity cardiac troponin I assays on patients presenting to an emergency department with suspected acute coronary syndrome
Less time in emergency department, but with what outcomes and at what cost?
Thomas P Y Yip MB BS(Hons), FRACP, FCSANZ · Heather M Pascoe MB BS(Hons), BMedSci · Stephen E Lane BSc(Hons), PhD
All that is irregular is not AF!
The 12-lead ECG holds the clues to distinguish between ventricular and supraventricular tachycardia
Colin Machado MB BS · Khang-Li Looi MB ChB, FRACP · Ajita Kanthan MB BS, FRACP · David C Adam MB BS, FRACP
Cardiopulmonary arrest and mortality trends, and their association with rapid response system expansion
Objectives: To understand the changes in the population incidence of inhospital cardiopulmonary arrest (IHCA) and mortality associated with the introduction of rapid response systems (RRSs). Design, setting and participants: Population-based study of 9 221 138 hospital admissions in 82 public acute hospitals in New South Wales, using data linked to a death registry, from 1 Jan 2002 to 31 Dec 2009. Main outcome measures: Changes in IHCA, IHCA-related mortality, hospital mortality and proportion of IHCA patients surviving to hospital discharge. Results: RRS uptake increased from 32% in 2002 to 74% in 2009. This increase was associated with a 52% decrease in IHCA rate, a 55% decrease in IHCA-related mortality rate, a 23% decrease in hospital mortality rate and a 15% increase in survival to discharge after an IHCA (all P < 0.01). The adjusted absolute reductions in IHCA-related mortality and hospital mortality were 1.49 (95% CI, 1.30–1.68) and 4.05 (95% CI, 3.17–4.76) patients per 1000 admissions, respectively. The decrease in IHCA incidence rate accounted for 95% of the reduction in IHCA-related mortality. In contrast, the increase in IHCA survival accounted for only 5% of the reduction in IHCA-related mortality. Conclusions: During nearly a decade, as RRSs were progressively introduced, there was a coincidental reduction in IHCA, IHCA-related deaths and hospital mortality and an increased survival to hospital discharge after an IHCA. Reduced IHCA incidence, rather than improved postcardiac arrest survival, was the main contributor to the reduction in IHCA mortality.
Jack Chen MB BS, PhD, MBA(Exec) · Lixin Ou MBA, MPH, PhD · Kenneth M Hillman MD, FRCA, FCICM · Arthas Flabouris MD, FCICM, FANZCA · Rinaldo Bellomo MD, FCICM, FRACP · Stephanie J Hollis BSc, MMedSc, PhD · Hassan Assareh PhD, MEng, MSc(Manag)
A framework for overcoming disparities in management of acute coronary syndromes in the Australian Aboriginal and Torres Strait Islander population. A consensus statement from the National Heart Foundation of Australia
Every Indigenous patient with ACS should be able to expect a coordinated, patient-centred pathway of care
Marcus K Ilton MB BS, FRACP · Warren F Walsh MB BS, FRACP · Alex D H Brown BMed, MPH, PhD · Philip A Tideman FRACP, FCSANZ · Christopher J Zeitz MB BS, PhD · Jinty Wilson MBA
Melbourne takes the world to heart - and vice versa
Highlights from the World Heart Federation’s World Congress of Cardiology in Melbourne
Stephen R Leeder MD, PhD, FRACP
Welcoming global progress in achieving heart health
We have come so far with achievements in cardiovascular disease control, but have so far yet to travel
Stephen Leeder
Australia's role in improving global cardiovascular health
Do Australian trends in cardiovascular disease have lessons for other countries?
Peter L Thompson AM, MD, FRACP, FACC
Dipeptidyl peptidase-4 inhibitors and cardiovascular safety
Recent cardiovascular outcome trials confirm the safety of DPP-4 inhibitors, but new questions emerge
Timothy M E Davis DPhil, FRCP, FRACP
With great power comes great responsibility
Why can television broadcast dubious scientific material without disclosing the experts’ conflicts of interest?
Daniel D L Bernal · Luke R E Bereznicki · Gregory M Peterson
Age, CKD and other kidney messages
World Kidney Day 2014 will promote discerning management for older patients
David C Harris MD, BS, FRACP · John Feehally DM, FRCP
Renal sympathetic denervation for resistant hypertension in a patient with a single kidney
An effective and well-tolerated treatment for resistant hypertension
Bo Xu · Robert J Whitbourn
The cat and the nap
While dogs can detect some cancers, cats might have other diagnostic talents
William H Seligman BA(Hons), BM BCh · Ari Manuel MB BS, MRCP, BSc
Cardiology networks: improving the management of acute coronary syndromes
Long distances to advanced cardiac care are an Australian reality. Optimal access to timely care must be a national objective.
Gerard E Carroll AM, MB BS(Hons), FRACP FCSANZ · Peter L Thompson AM, FRACP, FACC, MBA
Primary prevention of cardiovascular disease: new guidelines, technologies and therapies
Does a formulaic approach based on traditional risk factors measure up?
Duncan J Campbell
Primary prevention of cardiovascular disease: new guidelines, technologies and therapies
Does a formulaic approach based on traditional risk factors measure up?
Constantine N Aroney
Primary prevention of cardiovascular disease: new guidelines, technologies and therapies
Does a formulaic approach based on traditional risk factors measure up?
Mark R Nelson · Jennifer A Doust
Acute myopericarditis following intravenous zoledronic acid for the treatment of Paget’s disease
Bisphosphonates aren’t known to cause myocardial injury, but zoledronic acid may be an exception
Monique R Watts · Andris H Ellims · David S Eccleston
Impact of a regionalised clinical cardiac support network on mortality among rural patients with myocardial infarction
Has access to expert risk stratification and early invasive management closed the gap for rural patients?
Philip A Tideman MB BS, FRACP · Rosy Tirimacco BSc · David P Senior MB BS, MSc, FACRRM · John J Setchell PhD, BM BS · Luan T Huynh MB BS, PhD, FRACP · Rosanna Tavella BSc, PhD · Philip E G Aylward MA, BM BCh, PhD · Derek P B Chew MB BS, MPH, FRACP
Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain
Good diagnostic accuracy could have a major impact on health service delivery
William A Parsonage DM, MRCP, FRACP · Jaimi H Greenslade BPsych(Hons), PhD · Christopher J Hammett MB ChB, FRACP · Arvin Lamanna MB BS, FRACP · Jillian R Tate BSc(Hons), MSc · Jacobus P Ungerer MB ChB, MMed, FRCPA · Kevin Chu MB BS, MSc · Martin Than MB BS · Anthony F T Brown MB ChB · Louise Cullen MB BS